ATHE Research and Charts

ATHE - Alterity Therapeutics Ltd ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-04-03)

Last 2.94	Change ⇓ -0.20 (-6.53%)	Volume 24,181
	Open 3.05	High 3.05	Low 2.87

8EMA (Daily) 3.30	40EMA (Daily) 3.60	50EMA (Daily) 3.55	STO (Daily) 5.922	MACD Hist (Daily) -0.175
8EMA (Weekly) 3.559	40EMA (Weekly) 2.77	50EMA (Weekly) 2.64	STO (Weekly) 37.177	MACD Hist (Weekly) -0.209


Company Profile
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.